|
1
|
Refaat A, Abdelhamed S, Yagita H, Inoue H,
Yokoyama S, Hayakawa Y and Saiki I: Berberine enhances tumor
necrosis factor-related apoptosis-inducing ligand-mediated
apoptosis in breast cancer. Oncol Lett. 6:840–844. 2013.PubMed/NCBI
|
|
2
|
Zhang Y, Li X, Zhang Q, Li J, Ju J, Du N,
Liu X, Chen X, Cheng F, Yang L, et al: Berberine hydrochloride
prevents postsurgery intestinal adhesion and inflammation in rats.
J Pharmacol Exp Ther. 349:417–426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakurai H: Targeting of TAK1 in
inflammatory disorders and cancer. Trends Pharmacol Sci.
33:522–530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Keane MM, Ettenberg SA, Nau MM, Russell EK
and Lipkowitz S: Chemotherapy augments TRAIL-induced apoptosis in
breast cell lines. Cancer Res. 59:734–741. 1999.PubMed/NCBI
|
|
5
|
Tolcher AW, Mita M, Meropol NJ, von Mehren
M, Patnaik A, Padavic K, Hill M, Mays T, McCoy T, Fox NL, et al:
Phase I pharmacokinetic and biologic correlative study of
mapatumumab, a fully human monoclonal antibody with agonist
activity to tumor necrosis factor-related apoptosis-inducing ligand
receptor-1. J Clin Oncol. 25:1390–1395. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dyer MJ, MacFarlane M and Cohen GM:
Barriers to effective TRAIL-targeted therapy of malignancy. J Clin
Oncol. 25:4505–4506. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abdelhamed S, Yokoyama S, Refaat A, Ogura
K, Yagita H, Awale S and Saiki I: Piperine enhances the efficacy of
TRAIL-based therapy for triple-negative breast cancer cells.
Anticancer Res. 34:1893–1899. 2014.PubMed/NCBI
|
|
8
|
Refaat A, Abd-Rabou A and Reda A: TRAIL
combinations: The new ‘trail’ for cancer therapy (Review). Oncol
Lett. 7:1327–1332. 2014.PubMed/NCBI
|
|
9
|
Xu L, Zhang Y, Liu J, Qu J, Hu X, Zhang F,
Zheng H, Qu X and Liu Y: TRAIL-activated EGFR by Cbl-b-regulated
EGFR redistribution in lipid rafts antagonises TRAIL-induced
apoptosis in gastric cancer cells. Eur J Cancer. 48:3288–3299.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu L, Qu X, Li H, Li C, Liu J, Zheng H and
Liu Y: Src/caveolin-1-regulated EGFR activation antagonizes
TRAIL-induced apoptosis in gastric cancer cells. Oncol Rep.
32:318–324. 2014.PubMed/NCBI
|
|
11
|
Choo MK, Kawasaki N, Singhirunnusorn P,
Koizumi K, Sato S, Akira S, Saiki I and Sakurai H: Blockade of
transforming growth factor-beta-activated kinase 1 activity
enhances TRAIL-induced apoptosis through activation of a caspase
cascade. Mol Cancer Ther. 5:2970–2976. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishimura M, Shin MS, Singhirunnusorn P,
Suzuki S, Kawanishi M, Koizumi K, Saiki I and Sakurai H:
TAK1-mediated serine/threonine phosphorylation of epidermal growth
factor receptor via p38/extracellular signal-regulated kinase:
NF-{kappa}B-independent survival pathways in tumor necrosis factor
alpha signaling. Mol Cell Biol. 29:5529–5539. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang C, Chen T, Zhang N, Yang M, Li B, Lü
X, Cao X and Ling C: Melittin, a major component of bee venom,
sensitizes human hepatocellular carcinoma cells to tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
by activating CaMKII-TAK1-JNK/p38 and inhibiting IkappaBalpha
kinase-NFkappaB. J Biol Chem. 284:3804–3813. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Refaat A Aminullah, Zhou Y, Kawanishi M,
Tomaru R, Abdelhamed S, Shin MS, Koizumi K, Yokoyama S, Saiki I and
Sakurai H: Role of tyrosine kinase-independent phosphorylation of
EGFR with activating mutation in cisplatin-treated lung cancer
cells. Biochem Biophys Res Commun. 458:856–861. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tong J, Taylor P, Peterman SM, Prakash A
and Moran MF: Epidermal growth factor receptor phosphorylation
sites Ser991 and Tyr998 are implicated in the regulation of
receptor endocytosis and phosphorylations at Ser1039 and Thr1041.
Mol Cell Proteomics. 8:2131–2144. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Refaat A, Zhou Y, Suzuki S, Takasaki I,
Koizumi K, Yamaoka S, Tabuchi Y, Saiki I and Sakurai H: Distinct
roles of transforming growth factor-beta-activated kinase 1
(TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in
human T cell lymphotropic virus 1-transformed T helper 17 cells
producing interleukin-9. J Biol Chem. 286:21092–21099. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SJ, Noh HJ, Sung EG, Song IH, Kim JY,
Kwon TK and Lee TJ: Berberine sensitizes TRAIL-induced apoptosis
through proteasome-mediated downregulation of c-FLIP and Mcl-1
proteins. Int J Oncol. 38:485–492. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zaidi SF, Refaat A, Zhou Y, Sualeh
Muhammad J, Shin MS, Saiki I, Sakurai H and Sugiyama T:
Helicobacter pylori induces serine phosphorylation of EGFR via
novel TAK1-p38 activation pathway in an HB-EGF-independent manner.
Helicobacter. Feb 23–2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Y, Tanaka T, Sugiyama N, Yokoyama S,
Kawasaki Y, Sakuma T, Ishihama Y, Saiki I and Sakurai H:
p38-Mediated phosphorylation of Eps15 endocytic adaptor protein.
FEBS Lett. 588:131–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
